Kiromic Biopharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kiromic Biopharma, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q1 2022.
  • Kiromic Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $18.2K.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $18.2K Mar 31, 2022 10-Q 2022-05-13
Q3 2021 $77K -$252K -76.6% Sep 30, 2021 10-Q 2022-03-11
Q2 2021 $77.8K -$365K -82.4% Jun 30, 2021 10-Q 2021-08-13
Q3 2020 $329K Sep 30, 2020 10-Q 2022-03-11
Q2 2020 $443K Jun 30, 2020 10-Q 2021-08-13
Q2 2020 $9.43M Jun 8, 2020 10-K 2022-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.